Comparison the effect of 2 doses of intraconary adenosine in STEMI patients

Comparison the effect of 120 and 1000 moicrogram intracronary adenosine on noreflow and st resolution in STEMI patients undergoing primary PCI

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201610308903N2

Enrollment

Registered

2017-01-06

Start date

2016-08-08

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute myocardial infarction. myocardial infarction specified as acute or with a stated duration of 4 weeks (28 days) or less from onset

Interventions

Injection of intracoronary adenosine.

Treatment - Drugs

Injection of intracoronary adenosine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Includion criteria: all patients with STEMI and candidate for primary PCI Exclusion criteria: patients without using of adenosine or stent

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
ST resolution. Timepoint: First ECG in the CCU after PPCI. Method of measurement: Decrease of ST elevation in the ECG.;No reflow. Timepoint: After stent deployment. Method of measurement: During angiography.	—

Secondary

Measure	Time frame
Slow flow. Timepoint: After stent deployment. Method of measurement: During angiography.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Fatehi

Shahid beheshti university of medical sciences

fatehiaref@ gmail.com+98 21 2208 3106

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026